- Home
- UAL vs GEHC Comparison
UAL vs GEHC Comparison
Compare UAL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAL | GEHC |
|---|---|---|
| Founded | 1934 | 1892 |
| Country | United States | United States |
| Employees | 87000 | N/A |
| Industry | Air Freight/Delivery Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9B | 35.8B |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | UAL | GEHC |
|---|---|---|
| Price | $91.51 | $73.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | ★ $134.19 | $91.17 |
| AVG Volume (30 Days) | ★ 6.0M | 2.9M |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.19% |
| EPS Growth | ★ 7.94 | 4.84 |
| EPS | ★ 10.20 | 4.55 |
| Revenue | ★ $37,736,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $9.22 | $7.06 |
| Revenue Next Year | $6.58 | $4.50 |
| P/E Ratio | ★ $9.00 | $16.40 |
| Revenue Growth | 3.23 | ★ 4.84 |
| 52 Week Low | $52.00 | $57.65 |
| 52 Week High | $119.21 | $89.77 |
Technical Indicators
Market Signals| Indicator | UAL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 30.85 |
| Support Level | $88.48 | $69.34 |
| Resistance Level | $94.01 | $74.09 |
| Average True Range (ATR) | 5.88 | 2.17 |
| MACD | -2.10 | -0.98 |
| Stochastic Oscillator | 21.12 | 6.18 |
Price Performance
Historical ComparisonAbout UAL United Airlines Holdings Inc.
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).